Effect of adalimumab on experimental corneal neovascularization model.
Dilek OzkayaUmut KaracaGülşah Usta SofuMehtap SavranMeltem ÖzgöçmenAlper ErtuğrulPublished in: International ophthalmology (2023)
Both BEVA and ADA were effective in inhibiting CNV. Subconjunctival ADA seems to be more effective than BEVA in terms of inhibiting VEGF expression. Further experimental studies about ADA and BEVA are needed.